Integral Health Asset Management’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-100,000	Closed	-$2.35M	–	95
2024 Q2	$2.35M	Hold	100,000	–	–	0.22%	67
2024 Q1	$3.79M	Buy	+100,000	New	+$3.79M	0.35%	66